Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001062993-21-004867)

Filing Details

Accession Number:: 0001062993-21-004867
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-05-19 17:02:26
Reporting Period:: 2021-05-17

Accepted Time:: 2021-05-19 17:02:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
819050	Brickell Biotech Inc.	BBI	Biological Products, (No Disgnostic Substances) (2836)	930948554

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1758842	R. David Mcavoy	C/O Brickell Biotech, Inc. 5777 Central Avenue, Suite 102 Boulder CO 80301	General Counsel And Cco	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-05-17	18,622	$0.80	110,755	No	4	P	Direct
Common Stock	Acquisiton	2021-05-17	7,980	$0.80	13,980	No	4	P	Indirect	By Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	By Spouse

Footnotes

Represents the purchase of 18,622 shares in multiple transactions, ranging in price from $0.7942 to $0.8097 per share, resulting in a weighted average purchase price of $0.806. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares purchased at each price within the range.